Figure 4
From: Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
Expression levels of DOCK4, SPARCL1, BCL10, GLI2, MS4A6A, and FNBP3 genes in healthy individuals (control) and chronic myeloid leukemia patients. Total RNA was extracted from purified mononuclear cells from peripheral blood samples. Transcript levels were quantified by real-time PCR and results are given as normalized gene expression. Horizontal bars indicate median expression values. Statistical significance: P < 0.001 for DOCK4; P < 0.01 for SPARCL1, BCL10, and GLI2; P < 0.05 for MS4A6A and FNBP3.